Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Oridion

Explore full profile

Innovative capnography solutions enhancing patient safety and clinical outcomes

Needham, United StatesFounded 1987Health Tech & Medtech
Valuation $50–100M Last recorded · 1997
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Oridion and the history behind them.

About Oridion

Oridion specializes in capnography, a technology used to monitor the concentration of carbon dioxide in respiratory gases, primarily serving healthcare providers and medical institutions. Operating in the medical technology market, Oridion's core product is its Microstream® capnography technology, which provides accurate and continuous monitoring of patients' respiratory status. The business model revolves around the sale of capnography devices, disposable accessories, and related software solutions. Revenue is generated through direct sales to hospitals, clinics, and other healthcare facilities, as well as through partnerships with medical device manufacturers. Oridion's technology is particularly valuable in critical care, emergency medicine, and anesthesia, where precise respiratory monitoring is crucial. The company aims to improve patient safety and clinical outcomes by providing reliable and easy-to-use capnography solutions.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
1987
Headquarters
Needham, United States
Employees
59
Open positions
None listed
Dealroom signal
38.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Biotechnology
Business model
Manufacturing
Client focus
b2c

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Apr 2012 $0 — Covidien —
OtherOther financing Dec 1999 $0 — Giza Venture Capital —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Oridion website traffic

Latest recorded traffic for Oridion is 250 monthly website visits. Oridion's team grew 0% over the past year.

Latest monthly visits250 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Jerusalem Global Ventures

Other known investors3 additional known investors

  • Covidien
  • Giza Venture Capital
  • Gemini Israel Ventures
Team profiled 15 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇮🇱 Israel40%
🇺🇸 United States20%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Oridion on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Oridion’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.